Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Sachdev Amit
Relationship:  
City:   Cambridge
State:   MA
   
Insider Summary:
  
   
Companies Owned :   2    
Direct Shares   71,325    

Indirect Shares

   7,447      
Direct Value   $26,276,609    

Indirect Value

   $3,536,953      
Total Shares   78,772      
Total Value   $29,813,561      


Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0 Vertex Pharmaceuticals Inc $26,276,609 Celladon Corp $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Vertex Pharmaceuticals Inc VRTX EVP Chief Patient & Ex... 2024-05-15 55,325 2024-05-15 7,447    Premium*  
            Celladon Corp CLDN 2022-03-11 16,000 2020-03-12 0    Premium*  
* Premium Members only  

Records found :    193         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 5 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2013-07-11 4 OE $33.28 $232,960 D/D 7,000 35,987 0 -
VRTX Vertex Pharmaceuticals In... EVP Chief Patient & Ext Af Off   •       –      –    2024-02-07 4 A $0.00 $0 D/D 7,114 79,608 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2022-02-24 4 D $227.86 $1,678,872 D/D (7,368) 48,210 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-17 4 D $211.75 $1,612,053 D/D (7,613) 55,929 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-02-13 4 AS $87.68 $673,733 D/D (7,684) 99,335 0 -
VRTX Vertex Pharmaceuticals In... EVP, CRO   •       –      –    2017-07-21 4 AS $158.05 $1,386,691 D/D (8,625) 90,710 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2021-02-18 4 AS $210.00 $1,962,366 D/D (9,264) 46,665 0 %
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-03-03 4 OE $18.93 $180,422 D/D 9,531 49,685 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-03-03 4 AS $49.50 $471,785 D/D (9,531) 40,154 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-14 4 AS $58.00 $552,798 D/D (9,531) 21,108 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-14 4 OE $32.16 $306,517 D/D 9,531 30,639 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-21 4 OE $32.16 $306,517 D/D 9,531 30,639 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2012-09-21 4 AS $59.00 $562,329 D/D (9,531) 21,108 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2023-08-10 4 AS $350.00 $3,510,850 D/D (10,031) 58,814 0 %
VRTX Vertex Pharmaceuticals In... SVP, Public Policy,Gov Affairs   •       –      –    2008-02-07 4 A $0.01 $102 D/D 10,166 28,166 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2010-02-04 4 A $0.01 $102 D/D 10,166 50,983 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-02-03 4 A $0.01 $102 D/D 10,166 44,126 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2013-02-05 4 A $0.01 $102 D/D 10,166 28,987 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2016-02-03 4 AS $89.91 $923,460 D/D (10,166) 86,096 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-11 4 OE $131.89 $1,406,607 D/D 10,665 45,768 0 -
VRTX Vertex Pharmaceuticals In... EVP, Chief Patient Officer   •       –      –    2020-05-11 4 AS $276.25 $3,014,014 D/D (10,665) 35,103 0 %
VRTX Vertex Pharmaceuticals In... SVP, Global Gov. Strategy   •       –      –    2014-02-05 4 A $0.01 $119 D/D 11,875 38,436 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-01-18 4 OE $18.93 $225,532 D/D 11,914 51,752 0 -
VRTX Vertex Pharmaceuticals In... SVP, Corp Affairs & Pub Policy   •       –      –    2011-02-28 4 OE $18.93 $225,551 D/D 11,915 56,041 0 -
VRTX Vertex Pharmaceuticals In... EVP, Policy, Access & Value   •       –      –    2014-10-28 4 OE $39.05 $468,600 D/D 12,000 50,671 0 -
  193  Records found
  1   2   3   4   5  6   7   8      
  Page 5 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us